PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
07-May-2025 Fresenius Q1/25: Strong start to 2025 – #FutureFresenius Rejuvenate phase kicked-off with excellent momentum Fresenius
07-May-2025 Viatris Announces Quarterly Dividend Viatris
07-May-2025 Powering the Future of Lupus Treatments Worldwide Clinical Trials
07-May-2025 Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies ICON
07-May-2025 Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025 Novo Nordisk
07-May-2025 Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025 Gilead
07-May-2025 Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment Gilead
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
06-May-2025 Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy Xlife Sciences
06-May-2025 ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference ProQR
06-May-2025 Research advances on ‘displacing’ antibiotic resistance gene from bacteria University of Birmingham
06-May-2025 Health Secretary Tours Site of Scotland’s Largest Vaccine Producer Valneva Scotland
06-May-2025 Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier Microbiotica
06-May-2025 Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer Lundbeck
06-May-2025 Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer Lundbeck
06-May-2025 Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing Astraveus
06-May-2025 Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy Angelini Ventures
06-May-2025 ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer ENA Respiratory
02-May-2025 Alimentiv Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
02-May-2025 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy CSL Vifor